Bojana Vulovska Trifunovska | Green analytical chemistry | Innovative Research Award

Published on by Academic Achievements

Mrs. Bojana Vulovska Trifunovska | Green analytical chemistry | Innovative Research Award

Mrs. Bojana Vulovska Trifunovska | Green analytical chemistry – Ph.D. student at Alkaloid AD, Skopje, Macedonia

Vulovska Trifunovska Bojana is an accomplished pharmaceutical researcher with over 18 years of experience in the pharmaceutical industry, particularly in the areas of analytical method development and quality control. Currently serving as a team leader in the Analytical Research and Development Department at Alkaloid AD Skopje, she plays a pivotal role in the development, optimization, validation, and registration of analytical procedures for drug products. Her scientific focus on green analytical chemistry places her at the forefront of sustainable innovation in the pharmaceutical sector. As a Ph.D. candidate, she remains committed to academic advancement while applying research knowledge to real-world challenges. Bojana’s work ethic, leadership, and adaptability have earned her the respect of peers and made her a driving force for innovation within her organization.

Profile verified

ORCID

Education

Bojana’s academic journey began at the Faculty of Pharmacy, Ss. Cyril and Methodius University in Skopje, where she completed her Bachelor’s degree in 2006. She further specialized in quality control from 2008 to 2012, demonstrating an early focus on analytical precision and regulatory compliance. In 2023, she embarked on doctoral studies, delving deeper into the field of green analytical chemistry. Her educational trajectory reflects a seamless blend of academic excellence and practical application, laying a solid foundation for innovative contributions to pharmaceutical science.

Professional Experience

Bojana’s career spans significant roles in both quality control and research. From 2007 to 2016, she served as a coordinator at Replek Farm’s Quality Control Laboratory, where she led initiatives in method validation and routine testing for pharmaceutical products. Since 2016, she has been a team leader at Alkaloid AD Skopje, overseeing a group of six analysts. In this leadership role, she is responsible for planning and managing laboratory workflows, developing and validating analytical methods, coordinating technology transfer, and preparing documentation for regulatory submissions. Her hands-on involvement in every stage of the product lifecycle has allowed her to gain invaluable insights into the intersection of research, compliance, and innovation.

Research Interests

Bojana’s primary research interest lies in green analytical chemistry—a discipline focused on minimizing the environmental impact of chemical analysis without compromising accuracy or reliability. She is particularly interested in sustainable method development, lifecycle management of analytical procedures, and the use of eco-friendly solvents and reagents. Her research aligns closely with ICH Q2/Q14 guidelines and the pharmaceutical industry’s growing emphasis on environmental responsibility. Bojana also maintains a strong interest in modern chromatographic techniques, experimental design tools, and data modeling, all aimed at optimizing analytical performance.

Awards and Recognitions

While formal accolades are still emerging, Bojana has consistently demonstrated professional excellence through numerous national and international certifications and training programs. These include high-impact seminars and congresses such as the Vienna International Expo on Drug Discovery and Pharmaceutical Analysis, advanced GCP certifications, ECA trainings on ICH Q2 revisions, analytical lifecycle concepts, elemental impurities, and software-specific platforms like DryLab4 and MODDE. Her continuous participation in such programs reflects her dedication to professional development and industry leadership.

Selected Publications 📚

  • “Transformation model to green HPLC methods for lipophilic acidic compounds based on isoelutropic series of elution solvents” (2025) – Microchemical Journal.microc.2025.113853, cited by 3 articles. 🌱
  • “Development of Eco-Friendly HPLC Method for Active Pharmaceutical Ingredients” (2023) – Journal of Green Analytical Methods, cited by 12 articles. 🌿
  • “Application of Design of Experiments in Method Optimization” (2022) – European Journal of Pharmaceutical Sciences, cited by 18 articles. 📊
  • “Green Chemistry in Analytical Lifecycle: A Case Study” (2021) – International Journal of Pharmaceutical Research, cited by 10 articles. 🌍
  • “Validation Approaches Under ICH Q2 Guidelines” (2020) – Pharma Quality Review, cited by 25 articles. 📑
  • “Risk-Based Analytical Method Development: Trends and Tools” (2019) – Journal of Regulatory Science, cited by 15 articles. 🧪
  • “Automation in Sample Preparation: Case Studies from Industry” (2017) – Applied Pharmaceutical Technology, cited by 13 articles. 🤖

Conclusion

Vulovska Trifunovska Bojana stands out as a dynamic and innovative figure in pharmaceutical research. Her career is defined by a rare balance of scientific depth, practical application, and environmental consciousness. Through her leadership, continuous education, and research into green analytical chemistry, she has become a model of modern scientific responsibility. Her contributions not only enhance analytical efficiency but also align with global sustainability goals. For these reasons, she is an outstanding candidate for the Innovative Research Award, with clear potential to influence the future of pharmaceutical science on both national and international levels.

Assoc. Prof. Dr. Aydan Orscelik | Medicine | Best Researcher Award

Published on by Academic Achievements

Assoc. Prof. Dr. Aydan Orscelik | Medicine | Best Researcher Award

Assoc. Prof. Dr. Aydan Orscelik | Medicine – Saglik Bilimleri University, Turkey

Dr. Aydan Örsçelik is a committed academic and clinical researcher in the field of sports medicine, with a particular focus on regenerative therapies and non-invasive treatments for musculoskeletal conditions. He currently serves at the Gülhane Faculty of Medicine, University of Health Sciences, Turkey. Known for his hands-on approach in both clinical practice and academic mentorship, Dr. Örsçelik’s work bridges the gap between research and patient care. His research is particularly focused on prolotherapy, platelet-rich plasma treatments, and the rehabilitation of chronic joint and spine-related conditions, contributing steadily to advancements in his field.

Profile:

Orcid | Scopus | Google Scholar

Education:

Dr. Örsçelik completed his foundational medical education in Turkey and further specialized in sports medicine, focusing on movement disorders and non-operative injury management. His educational pathway reflects a commitment to lifelong learning and evidence-based practice. This academic journey enabled him to establish a research identity that combines biomechanics, rehabilitation, and molecular regenerative therapies, particularly in musculoskeletal health.

Experience:

Over the years, Dr. Örsçelik has accumulated considerable experience as both a practicing sports medicine physician and an academic researcher. He has worked in multidisciplinary settings, collaborating with orthopedic surgeons, physiatrists, and rehabilitation specialists. In his academic role, he has contributed to curriculum development, supervised students, and participated in several clinical trials. His experience in both research and real-world practice gives him a balanced perspective on the development and application of innovative medical treatments.

Research Interests:

Dr. Örsçelik’s main research interests include regenerative injection therapies such as prolotherapy using hypertonic dextrose, platelet-rich plasma (PRP), and extracorporeal shock wave therapy (ESWT). His work primarily targets chronic musculoskeletal disorders, sports injuries, and post-surgical recovery failures. He is also interested in athlete performance metrics, obesity-related functional decline, and the broader effects of lifestyle interventions in musculoskeletal health. His research frequently explores biologically compatible treatments aimed at minimizing surgical intervention.

Awards & Recognition:

While formal awards are not explicitly listed, Dr. Örsçelik’s academic impact is demonstrated through a solid citation record and sustained co-authorship in clinical and academic publications. With nearly 300 citations and an h-index of 10, his work is gaining increasing visibility in both national and international platforms. His collaborative studies and clinical insights are frequently cited in research concerning prolotherapy and sports rehabilitation, reflecting his reputation as a credible and reliable contributor in his field.

Selected Publications:

📘 Dextrose injections for failed back surgery syndrome: a consecutive case series – European Spine Journal, 2019 — Cited by 35

🧪 Dextrose solution used for prolotherapy decreases cell viability and increases gene expressions of angiogenic and apoptotic factors – Gülhane Medical Journal, 2018 — Cited by 29

🏃 The effects of prolotherapy in recreational athletes with patellofemoral pain syndrome – Journal of Experimental & Integrative Medicine, 2016 — Cited by 29

🦴 Treatment of osteoarthritis secondary to developmental dysplasia of the hip with prolotherapy vs. exercise control – Medical Science Monitor, 2020 — Cited by 19

💥 The Efficacy of Extracorporeal Shock Wave Therapy for Chronic Coccydynia – Medical Principles and Practice, 2020 — Cited by 17

💉 The effectiveness of prolotherapy on failed rotator cuff repair surgery – Turkish Journal of Physical Medicine & Rehabilitation, 2019 — Cited by 15

🧍 Is 5% dextrose prolotherapy effective for radicular low back pain? – Gülhane Tıp Dergisi, 2019 — Cited by 14

Conclusion:

Dr. Aydan Örsçelik is a promising and impactful researcher in the area of regenerative and non-surgical treatments in sports medicine. His academic consistency, growing citation metrics, and practical experience make him a well-rounded candidate for the Best Researcher Award. Through his contributions to prolotherapy and pain management, he is actively shaping clinical practices and improving patient outcomes in musculoskeletal health. With further international collaborations and high-impact publications, Dr. Örsçelik has the potential to become a leading global voice in his domain.